Tagged with Chris Davis

Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.

From Phase 1 human trials for a Malaria vaccine, to studies aimed at treating osteoporosis and a number of trials into innovative life-saving stroke treatment, the Gold Coast Health & Knowledge Precinct is fast gaining a reputation as a leading location for clinical trials.